This is a synthetic peptide designed for use in combination with anti-SLC19A2 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
Aufreinigung
Purified
Applikationshinweise
Each Investigator should determine their own optimal working dilution for specific applications.
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Lyophilized
Rekonstitution
Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
Konzentration
1 mg/mL
Buffer
Final peptide concentration is 1 mg/mL in PBS.
Handhabung
Avoid repeated freeze-thaw cycles.
Lagerung
-20 °C
Informationen zur Lagerung
For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
Target
SLC19A2
(Solute Carrier Family 19 (Thiamine Transporter), Member 2 (SLC19A2))
Synonyme
SLC19A2 Peptide, TC1 Peptide, THMD1 Peptide, THT1 Peptide, THTR1 Peptide, TRMA Peptide, solute carrier family 19 member 2 Peptide, solute carrier family 19 (thiamine transporter), member 2 Peptide, Slc19a2 Peptide, SLC19A2 Peptide, slc19a2 Peptide
Hintergrund
This gene encodes the thiamin transporter protein. Mutations in this gene cause thiamin-responsive megaloblastic anemia syndrome (TRMA), which is an autosomal recessive disorder characterized by diabetes mellitus, megaloblastic anemia and sensorineural deafness.